Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dolutegravir Antiretroviral Monotherapy for HIV Trial
2014-005454-19Phase 4Terminated
- Sponsor
- Erasmus MC
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dolutegravir in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Erasmus MC. Primary endpoint: Primary virological efficacy endpoint. Started Feb 2015; status: terminated.
02
Drugs
dolutegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2014-005454-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005454-19.